These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 9699707)

  • 21. Mood elevating effect of fluoxetine in a diagnostically homogeneous inpatient population with major depressive disorder.
    von Bardeleben U; Holsboer F; Gerken A; Benkert O
    Int Clin Psychopharmacol; 1989 Jan; 4 Suppl 1():31-5. PubMed ID: 2644337
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Melatonin for sleep disturbance in children with neurodevelopmental disorders: prospective observational naturalistic study.
    Ayyash HF; Preece P; Morton R; Cortese S
    Expert Rev Neurother; 2015 Jun; 15(6):711-7. PubMed ID: 25938708
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Efficacy of prolonged release melatonin in insomnia patients aged 55-80 years: quality of sleep and next-day alertness outcomes.
    Wade AG; Ford I; Crawford G; McMahon AD; Nir T; Laudon M; Zisapel N
    Curr Med Res Opin; 2007 Oct; 23(10):2597-605. PubMed ID: 17875243
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Morning fluoxetine plus evening mianserin versus morning fluoxetine plus evening placebo in the acute treatment of major depression.
    Dam J; Ryde L; Svejsø J; Lauge N; Lauritsen B; Bech P
    Pharmacopsychiatry; 1998 Mar; 31(2):48-54. PubMed ID: 9562208
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Chronobiology, cognitive function and depressive symptoms in surgical patients.
    Hansen MV
    Dan Med J; 2014 Sep; 61(9):B4914. PubMed ID: 25186550
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Quetiapine monotherapy in the treatment of depressive episodes of bipolar I and II disorder: Improvements in quality of life and quality of sleep.
    Endicott J; Paulsson B; Gustafsson U; Schiöler H; Hassan M
    J Affect Disord; 2008 Dec; 111(2-3):306-19. PubMed ID: 18774180
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prolonged-release melatonin in Parkinson's disease patients with a poor sleep quality: A randomized trial.
    Ahn JH; Kim M; Park S; Jang W; Park J; Oh E; Cho JW; Kim JS; Youn J
    Parkinsonism Relat Disord; 2020 Jun; 75():50-54. PubMed ID: 32480307
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Use of slow-release melatonin in treatment-resistant depression.
    Dalton EJ; Rotondi D; Levitan RD; Kennedy SH; Brown GM
    J Psychiatry Neurosci; 2000 Jan; 25(1):48-52. PubMed ID: 10721684
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Trazodone for antidepressant-associated insomnia.
    Nierenberg AA; Adler LA; Peselow E; Zornberg G; Rosenthal M
    Am J Psychiatry; 1994 Jul; 151(7):1069-72. PubMed ID: 8010365
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The effects of fluoxetine on symptoms of insomnia in depressed patients.
    Satterlee WG; Faries D
    Psychopharmacol Bull; 1995; 31(2):227-37. PubMed ID: 7491373
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prolonged release melatonin in the treatment of primary insomnia: evaluation of the age cut-off for short- and long-term response.
    Wade AG; Crawford G; Ford I; McConnachie A; Nir T; Laudon M; Zisapel N
    Curr Med Res Opin; 2011 Jan; 27(1):87-98. PubMed ID: 21091391
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Efficacy of the combination of fluoxetine and perphenazine in the treatment of psychotic depression.
    Rothschild AJ; Samson JA; Bessette MP; Carter-Campbell JT
    J Clin Psychiatry; 1993 Sep; 54(9):338-42. PubMed ID: 8104930
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Fluoxetine augmentation of clozapine treatment in patients with schizophrenia.
    Buchanan RW; Kirkpatrick B; Bryant N; Ball P; Breier A
    Am J Psychiatry; 1996 Dec; 153(12):1625-7. PubMed ID: 8942462
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Sleep disorders in Parkinson's disease without dementia: a comparative randomized controlled study of melatonin and clonazepam].
    Litvinenko IV; Krasakov IV; Tikhomirova OV
    Zh Nevrol Psikhiatr Im S S Korsakova; 2012; 112(12):26-30. PubMed ID: 23388588
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of melatonin on depressive symptoms and anxiety in patients undergoing breast cancer surgery: a randomized, double-blind, placebo-controlled trial.
    Hansen MV; Andersen LT; Madsen MT; Hageman I; Rasmussen LS; Bokmand S; Rosenberg J; Gögenur I
    Breast Cancer Res Treat; 2014 Jun; 145(3):683-95. PubMed ID: 24756186
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A multicenter, placebo-controlled trial of melatonin for sleep disturbance in Alzheimer's disease.
    Singer C; Tractenberg RE; Kaye J; Schafer K; Gamst A; Grundman M; Thomas R; Thal LJ;
    Sleep; 2003 Nov; 26(7):893-901. PubMed ID: 14655926
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Therapeutic effects of vitamin D as adjunctive therapy to fluoxetine in patients with major depressive disorder.
    Khoraminya N; Tehrani-Doost M; Jazayeri S; Hosseini A; Djazayery A
    Aust N Z J Psychiatry; 2013 Mar; 47(3):271-5. PubMed ID: 23093054
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Fluoxetine, placebo, and tricyclic antidepressants in major depression with and without anxious features.
    Tollefson GD; Holman SL; Sayler ME; Potvin JH
    J Clin Psychiatry; 1994 Feb; 55(2):50-9. PubMed ID: 8077155
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Fluoxetine treatment for depression in patients with HIV and AIDS: a randomized, placebo-controlled trial.
    Rabkin JG; Wagner GJ; Rabkin R
    Am J Psychiatry; 1999 Jan; 156(1):101-7. PubMed ID: 9892304
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Fluoxetine treatment of dysthymia in the elderly.
    Nobler MS; Devanand DP; Kim MK; Fitzsimons LM; Singer TM; Turret N; Sackeim HA; Roose SP
    J Clin Psychiatry; 1996 Jun; 57(6):254-6. PubMed ID: 8666563
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.